Teishima, J., S. Inoue, T. Hayashi, K. Mita, Y. Hasegawa, M. Kato, M. Kajiwara, M. Shigeta, S. Maruyama, H. Moriyama, and S. Fujiwara. “Impact of the Systemic Immune-Inflammation Index for the Prediction of Prognosis and Modification of the Risk Model in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors”. Canadian Urological Association Journal, vol. 14, no. 11, June 2020, pp. E582-7, doi:10.5489/cuaj.6413.